Lombard Odier Asset Management (Switzerland)’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $549K | Sell |
6,073
-521
| -8% | -$43.6K | 0.02% | 365 |
|
|
2026
Q1 | $528K | Sell |
6,594
-7,458
| -53% | -$615K | 0.02% | 360 |
|
|
2025
Q4 | $1.2M | Sell |
14,052
-3,500
| -20% | -$287K | 0.05% | 224 |
|
|
2025
Q3 | $1.37M | Hold |
17,552
| – | – | 0.06% | 207 |
|
|
2025
Q2 | $1.37M | Buy |
17,552
+3,857
| +28% | +$288K | 0.07% | 202 |
|
|
2025
Q1 | $993K | Buy |
13,695
+1,013
| +8% | +$72.5K | 0.06% | 218 |
|
|
2024
Q4 | $939K | Buy |
12,682
+150
| +1% | +$10.5K | 0.07% | 215 |
|
|
2024
Q3 | $827K | Buy |
12,532
+511
| +4% | +$37.1K | 0.07% | 206 |
|
|
2024
Q2 | $1.11M | Sell |
12,021
-6,421
| -35% | -$569K | 0.11% | 153 |
|
|
2024
Q1 | $1.76M | Buy |
+18,442
| New | +$1.55M | 0.12% | 169 |
|
|
2023
Q3 | – | Sell |
-10,646
| Closed | -$1M | – | 147 |
|
|
2023
Q2 | $1M | Sell |
10,646
-1,106
| -9% | -$96.1K | 0.14% | 110 |
|
|
2023
Q1 | $972K | Buy |
11,752
+2,695
| +30% | +$212K | 0.08% | 201 |
|
|
2022
Q4 | $676K | Buy |
9,057
+4,854
| +115% | +$374K | 0.05% | 224 |
|
|
2022
Q3 | $347K | Sell |
4,203
-4,013
| -49% | -$386K | 0.03% | 214 |
|
|
2022
Q2 | $781K | Buy |
+8,216
| New | +$851K | 0.07% | 173 |
|
|
2022
Q1 | – | Sell |
-8,413
| Closed | -$1.09M | – | 241 |
|
|
2021
Q4 | $1.09M | Sell |
8,413
-7,109
| -46% | -$829K | 0.07% | 134 |
|
|
2021
Q3 | $1.68M | Buy |
15,522
+4,225
| +37% | +$482K | 0.1% | 117 |
|
|
2021
Q2 | $1.17M | Buy |
11,297
+892
| +9% | +$84.1K | 0.06% | 179 |
|
|
2021
Q1 | $870K | Sell |
10,405
-2,225
| -18% | -$188K | 0.06% | 169 |
|
|
2020
Q4 | $1.15M | Buy |
12,630
+1,909
| +18% | +$158K | 0.13% | 78 |
|
|
2020
Q3 | $856K | Buy |
+10,721
| New | +$837K | 0.09% | 163 |
|
|
2020
Q2 | – | Sell |
-4,413
| Closed | -$277K | – | 216 |
|
|
2020
Q1 | $277K | Sell |
4,413
-17,313
| -80% | -$1.25M | 0.04% | 288 |
|
|
2019
Q4 | $1.69M | Sell |
21,726
-10,971
| -34% | -$857K | 0.16% | 112 |
|
|
2019
Q3 | $2.4M | Buy |
32,697
+10,317
| +46% | +$725K | 0.26% | 70 |
|
|
2019
Q2 | $1.38M | Sell |
22,380
-6,726
| -23% | -$407K | 0.14% | 128 |
|
|
2019
Q1 | $1.86M | Sell |
29,106
-30,624
| -51% | -$1.75M | 0.19% | 96 |
|
|
2018
Q4 | $3.05M | Buy |
59,730
+48,819
| +447% | +$2.47M | 0.35% | 63 |
|
|
2018
Q3 | $633K | Hold |
10,911
| – | – | 0.06% | 218 |
|
|
2018
Q2 | $529K | Buy |
10,911
+5,319
| +95% | +$248K | 0.06% | 215 |
|
|
2018
Q1 | $260K | Sell |
5,592
-133,227
| -96% | -$5.79M | 0.03% | 318 |
|
|
2017
Q4 | $5.21M | Sell |
138,819
-30,000
| -18% | -$1.1M | 0.51% | 50 |
|
|
2017
Q3 | $6.15M | Sell |
168,819
-60,000
| -26% | -$2.29M | 0.6% | 44 |
|
|
2017
Q2 | $9.02M | Sell |
228,819
-60,000
| -21% | -$2.19M | 1.04% | 23 |
|
|
2017
Q1 | $9.06M | Buy |
288,819
+108,819
| +60% | +$3.41M | 1% | 29 |
|
|
2016
Q4 | $5.62M | Buy |
180,000
+127,200
| +241% | +$4.12M | 1.42% | 24 |
|
|
2016
Q3 | $2.12M | Buy |
52,800
+16,170
| +44% | +$609K | 0.51% | 36 |
|
|
2016
Q2 | $1.22M | Sell |
36,630
-14,925
| -29% | -$511K | 0.17% | 99 |
|
|
2016
Q1 | $1.52M | Buy |
51,555
+8,151
| +19% | +$225K | 0.18% | 92 |
|
|
2015
Q4 | $1.15M | Buy |
+43,404
| New | +$1.13M | 0.14% | 97 |
|
|
2015
Q3 | – | Sell |
-23,964
| Closed | -$569K | – | 314 |
|
|
2015
Q2 | $569K | Sell |
23,964
-123,906
| -84% | -$2.8M | 0.04% | 298 |
|
|
2015
Q1 | $3.51M | Buy |
147,870
+134,670
| +1,020% | +$3.02M | 0.39% | 51 |
|
|
2014
Q4 | $282K | Sell |
13,200
-47,592
| -78% | -$956K | 0.03% | 341 |
|
|
2014
Q3 | $1.04M | Buy |
60,792
+50,694
| +502% | +$800K | 0.03% | 520 |
|
|
2014
Q2 | $144K | Buy |
+10,098
| New | +$137K | 0.02% | 431 |
|
Other funds holding EW
Lombard Odier Asset Management (Switzerland)'s EW Position: Q2 2026 in Review
Lombard Odier Asset Management (Switzerland) reduced its Edwards Lifesciences (EW) stake by 7.9% in Q2 2026, selling an estimated $43.6K and leaving 6,073 shares worth $549K. The position accounts for 0.02% of the portfolio, ranked #365.
Lombard Odier Asset Management (Switzerland) first reported a position in EW in Q2 2014 and has held it in 44 quarters since. The position peaked at $9.06M in Q1 2017. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Lombard Odier Asset Management (Switzerland) held 6,073 shares of Edwards Lifesciences worth $549K as of Q2 2026.
- Lombard Odier Asset Management (Switzerland) sold 521 Edwards Lifesciences shares in Q2 2026, an estimated $43.6K.
- Edwards Lifesciences made up 0.02% of Lombard Odier Asset Management (Switzerland)'s portfolio in Q2 2026, its #365 holding.
- Lombard Odier Asset Management (Switzerland) first reported a position in Edwards Lifesciences in Q2 2014 and has held it in 44 quarters since.
- Lombard Odier Asset Management (Switzerland)'s Edwards Lifesciences position peaked at $9.06M in Q1 2017.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2026, filed 14 Aug 2026.